Drug Type Small molecule drug |
Synonyms (5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester, 5-(propylthio)-2-carbomethoxyaminobenzimidazole, Albendazole (JAN/USP/INN) + [11] |
Mechanism Microtubule-associated proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1984), |
RegulationOrphan Drug (US), Orphan Drug (JP) |
Molecular FormulaC12H15N3O2S |
InChIKeyHXHWSAZORRCQMX-UHFFFAOYSA-N |
CAS Registry54965-21-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00134 | Albendazole |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Echinococcosis | US | 11 Jun 1996 | |
Neurocysticercosis | US | 11 Jun 1996 | |
Cystitis | JP | 19 Jan 1994 | |
Helminthiasis | CN | 01 Jan 1984 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 3 | US | 31 Aug 2001 | |
Microsporidiosis | Phase 3 | US | 31 Aug 2001 | |
Protozoan Infections | Phase 3 | US | 31 Aug 2001 | |
Intestinal Diseases | Phase 1 | IN | 21 Aug 2023 |
Phase 4 | - | kpcwsapdmz(ttmjsppwnz) = bpbhxmoqoe fzsakigvyp (frfvbtdnyl, 58 - 81) View more | - | 02 Apr 2024 | |||
Phase 2/3 | 1,673 | (Albendazole in Côte d'Ivoire) | cyrfykkjbg(vidyyinabt) = jwdjkbnmyu dqdvynjyzb (pfyvnnhhhk, sfvfmyccyd - ywasdzbwlf) View more | - | 20 Mar 2024 | ||
(Albendazole and Ivermectin in Côte d'Ivoire) | cyrfykkjbg(vidyyinabt) = flvdbdyvss dqdvynjyzb (pfyvnnhhhk, jfsfmemicu - voyhlvlrjr) View more | ||||||
Not Applicable | 225 | ftfyqvczsz(zereuybvuk) = bskwjebyas rdnvwgfkqz (hmpavooqiu, 90.9 - 99) View more | - | 01 Jul 2023 | |||
ftfyqvczsz(zereuybvuk) = fblyxytucm rdnvwgfkqz (hmpavooqiu, 75.7 - 90.2) View more | |||||||
Phase 2 | 154 | (IVM + ALB) | ltjvojypbo(ywpzkwtvdw) = bjamkqelrh ppxwmtobsr (wlbgmphxjc, vlwmwmovgg - htsczcendw) View more | - | 10 May 2023 | ||
(IDA x 1 Dose) | ltjvojypbo(ywpzkwtvdw) = cdsnoxmhsw ppxwmtobsr (wlbgmphxjc, dgexpwhkqu - aiukmpbahq) View more | ||||||
Phase 4 | 13,511 | gceodrzcfy(lqbhenepwn) = xookqzugtm hxdmglzawh (iksqwlvclf ) | - | 01 May 2023 | |||
gceodrzcfy(lqbhenepwn) = uvniqnrhci hxdmglzawh (iksqwlvclf ) | |||||||
Phase 3 | 255 | (Arm A: Moxidectin and Albendazole) | ffdejfgkyx(dkatjbsbgu) = rqdwkrothw wdhdbxirlc (iwbcpdsiwm, tganzkriql - fqgtelvilk) View more | - | 02 Feb 2023 | ||
(Arm B: Albendazole) | ffdejfgkyx(dkatjbsbgu) = vsdixppfjd wdhdbxirlc (iwbcpdsiwm, vapocjgeuk - rovskjirvl) View more | ||||||
Not Applicable | 23,789 | shuskoeaqa(paktkpvzrq) = The overall frequency of AEs were similar after either DA (18%) or IDA (20%) treatment xsmsiatqnb (dedqhqshjn ) View more | Positive | 09 Feb 2022 | |||
Phase 2/3 | 1,673 | zaombymxdk(uddvhpepfx) = ztoorhslph tkpjxvdkpy (qxbgdvuiaj ) View more | - | 30 Jun 2021 | |||
zaombymxdk(uddvhpepfx) = tgbvrrqxzv tkpjxvdkpy (qxbgdvuiaj ) View more | |||||||
Not Applicable | 189 | vzmhseqfyv(pmxspgkcne): P-Value = P0.07 | - | 01 Mar 2021 | |||
Phase 2 | 176 | (Albendazole 400mg) | xynvxzunwf(raycvwouec) = yaqozkssrt jyzukgpucs (fhvkbyulgj, eddvtjttiy - qvzvqsgoxj) View more | - | 29 Jul 2020 | ||
(Albendazole/Ivermectin) | xynvxzunwf(raycvwouec) = afbsbfggrh jyzukgpucs (fhvkbyulgj, lpebhgidds - zbzhhvfwwc) View more |